All Stories

  1. Active Ingredients of Natural Sources and their Applications
  2. Current Highlights About the Safety of Inorganic Nanomaterials in Healthcare
  3. Thermo-mechanical and adhesive properties of polymeric films based on ZnAl-hydrotalcite composites for active wound dressings
  4. Optimisation of phenol extraction from wine using layered double hydroxides and technological evaluation of the bioactive-rich powder
  5. Development of Smart Semisolid Formulations to Enhance Retinoic Acid Topical Application
  6. Structural Characterisation of Complex Layered Double Hydroxides and TGA-GC-MS Study on Thermal Response and Carbonate Contamination in Nitrate- and Organic-Exchanged Hydrotalcites
  7. Gastroretentive inorganic–organic hybrids to improve class IV drug absorption
  8. Hydrogel blends with adjustable properties as patches for transdermal delivery
  9. Hydrotalcite composites for an effective fluoride buccal administration: A new technological approach
  10. Development of a Fast and Clean Intercalation Method for Organic Molecules into Layered Double Hydroxides
  11. Preformulation studies of mucoadhesive tablets for carbamazepine sublingual administration
  12. Structural characterization and thermal and chemical stability of bioactive molecule–hydrotalcite (LDH) nanocomposites
  13. Inorganic matrices: an answer to low drug solubility problem
  14. Influence of the Nanocomposite MgAl-HTlc on Gastric Absorption of Drugs: In Vitro and Ex Vivo Studies
  15. Use of SBA-15 for furosemide oral delivery enhancement
  16. New oral solid dosage form for furosemide oral administration
  17. MCM-41 for furosemide dissolution improvement
  18. Immobilization of kojic acid in ZnAl-hydrotalcite like compounds
  19. Preformulation studies on host–guest composites for oral administration of BCS class IV drugs: HTlc and furosemide
  20. Intercalation and release of antiinflammatory drug diclofenac into nanosized ZnAl hydrotalcite-like compound
  21. New solid mucoadhesive systems for benzydamine vaginal administration
  22. Effects of hydrotalcite-like nanostructured compounds on biopharmaceutical properties and release of BCS class II drugs: The case of flurbiprofen
  23. New Efficient Intercalation of Bioactive Molecules into Layered Double Hydroxide Materials by Solid-State Exchange: Anin SituXRPD Study
  24. Econazole Nitrate-Loaded MCM-41 for an Antifungal Topical Powder Formulation
  25. ChemInform Abstract: Convenient Synthesis of 2-Aminonaphthalene-1-thiol and 3- Aminoquinoline-4-thiol and Cyclocondensations to 1,4-Thiazino and 1,4- Thiazepino Derivatives.
  26. ChemInform Abstract: Synthesis and Pharmacological Activity of Imidazo(2,1-b)benzothiazole Acids.
  27. ChemInform Abstract: NMR Spectra and Conformational Analysis of Some 4,5-Dihydro-s-triazolo( 3,4-d)(1,5)benzothiazepine Derivatives.
  28. ChemInform Abstract: Synthesis of Several New 5-Nitro-1,4-benzothiazine and 6-Nitro-1,5-benzothiazepine Derivatives.
  29. ChemInform Abstract: Synthesis and Antimicrobial Activity of Some New Derivatives of 6,12-Dihydroindolo[2,1-b]quinazolin-6,12-dione.
  30. ChemInform Abstract: Synthesis of Some New 1,4-Benzothiazine and 1,5-Benzothiazepine Tricyclic Derivatives with Structural Analogy with TIBO and Their Screening for Anti-HIV Activity.
  31. Chlorhexidine MCM-41 Mucoadhesive Tablets for Topical Use
  32. Effect of gliclazide immobilization into layered double hydroxide on drug release
  33. FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration
  34. Formulation studies of benzydamine mucoadhesive formulations for vaginal administration
  35. Novel composite microparticles for protein stabilization and delivery
  36. Eudragit® and hydrotalcite-like anionic clay composite system for diclofenac colonic delivery
  37. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels
  38. Role of mesoporous silicates on carbamazepine dissolution rate enhancement
  39. Rheological and functional characterization of new antiinflammatory delivery systems designed for buccal administration
  40. Influence of Compression Force on The Behavior of Mucoadhesive Buccal Tablets
  41. Physicochemical characterization and release mechanism of a novel prednisone biodegradable microsphere formulation
  42. Sunscreen immobilization on ZnAl-hydrotalcite for new cosmetic formulations
  43. Hydrotalcite-like compounds: Versatile layered hosts of molecular anions with biological activity
  44. Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen
  45. Ketoprofen poly(lactide-co-glycolide) physical interaction
  46. Use of calcined Mg–Al–hydrotalcite to enhance the stability of celecoxib in the amorphous form
  47. Use of anionic clays for photoprotection and sunscreen photostability: Hydrotalcites and phenylbenzimidazole sulfonic acid
  48. Development of liposomal capreomycin sulfate formulations: Effects of formulation variables on peptide encapsulation
  49. Anionic clays for sunscreen agent safe use: Photoprotection, photostability and prevention of their skin penetration
  50. Evaluation and Optimization of the Conditions for an Improved Ferulic Acid Intercalation into a Synthetic Lamellar Anionic Clay
  51. UV spectroscopy and reverse-phase HPLC as novel methods to determine Capreomycin of liposomal fomulations
  52. Development of mucoadhesive patches for buccal administration of ibuprofen
  53. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS
  54. Leucinostatin-A loaded nanospheres: characterization and in vivo toxicity and efficacy evaluation
  55. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease
  56. Unilamellar vesicles as potential capreomycin sulfate carriers: Preparation and physicochemical characterization
  57. Effect of hydrotalcite-like compounds on the aqueous solubility of some poorly water-soluble drugs
  58. Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: Uptake of diclofenac for a controlled release formulation
  59. Intercalation Compounds of Hydrotalcite-like Anionic Clays With Anti-inflammatory Agents, II: Uptake of Diclofenac for a Controlled Release Formulation
  60. Microporous material from kanemite for drug inclusion and release
  61. Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents — I. Intercalation and in vitro release of ibuprofen
  62. How to improve the readability of the patient package leaflet: a survey on the use of colour, print size and layout
  63. COMPREHENSIBILITY OF THE PACKAGE LEAFLETS OF ALL MEDICINAL PRODUCTS FOR HUMAN USE: A QUESTIONNAIRE SURVEY ABOUT THE USE OF SYMBOLS AND PICTOGRAMS
  64. SYNTHESIS OF SOME NOVEL ANNELATED 1,4-BENZOTHIAZINE AND 1,5- BENZOTHIAZEPINE DERIVATIVES AS POTENTIAL ANTIMICROBIAL AND CYTOSTATIC AGENTS(1)
  65. NMR spectra and conformational analysis of some 4,5-dihydro-s-triazolo[3,4-d][1,5]benzothiazepine derivatives
  66. Convenient Synthesis of 2-Aminonaphthalene-1-thiol and 3-Aminoquinoline-4-thiol and Cyclocondensations to 1,4-Thiazino and 1,4-Thiazepino Derivatives
  67. Synthesis and Biological Activity ofN-2 Alkylamino Derivatives of 4,5-Dihydro-s-triazolo[3,4-d]-1,5-benzothiazepine